A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
Clinical trial NCT05866614 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05866614
- Sponsor
- Celltrion
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-13
- Primary completion
- 2027-03-01
- Enrollment
- 881
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.